Strategic Approaches to Improving Gynecologic Cancer Diagnosis and Treatment

September 6, 2006

PENN Online Today

Clinical advances and research offer methods to potentially extend cancer survival and reduce mortality.

A recent study by the Gynecologic Oncology Group (NEJM 2006; 354: 34-43) suggested that intraperitoneal chemotherapy offers a clinical advantage in the treatment of ovarian cancer, potentially increasing survival of women with advanced ovarian cancer. In the multi-center study, overall survival for 205 women with surgically debulked stage III ovarian cancer that were treated with a combination of intraperitoneal and intravenous chemotherapy was a median of 65.6 months – 25 percent longer than the 210 women who only received chemotherapy intravenously... Read More